TRUMBULL, Conn., Sept. 20, 2016 -- ZetrOZ Systems, LLC, announced today that the company’s innovative FDA cleared wearable-active ultrasound device – called sam® Sport – is now used widely by professional athletic trainers and physiotherapists in the NFL, NBA, NHL, MLS, MLB and USA Teams.
Introduced to the healthcare market in 2014, sam® Sport is clinically proven to increase collagen laydown (accelerates the natural healing process in soft tissue), brings oxygenated blood to muscle tissues, accelerates angiogenesis (stimulates capillary development) and increases blood flow, which is important for muscle recovery, healing and healthy tissues.
sam® Sport (www.samsport.com) – manufactured in the United States and available by prescription from licensed healthcare professionals – is revolutionizing the treatment of soft-tissue injuries by significantly accelerating healing times, eliminating surgical procedures and reducing pain medication use.
Rick Guter, the head athletic trainer for USA Women’s Soccer, uses sam® Sport to treat both acute and chronic injuries. “For our soccer players we have a number of chronic groin muscle problems that have developed over time and this is one of the first devices that the athletes actually ask for,” he said.
Wally Blasé, former head athletic trainer for the NBA’s Atlanta Hawks and Chief Executive Officer of performance LLC works to rehabilitate professional athletes across the United States. “The key advantages of sam® Sport is the delivery of long-term ultrasound or sustained acoustic medicine, and to use it for deep-heat warming-up, recovery and treating injuries,” said Blasé. “The sam® Sport is nice, as you can put it on an athlete, set the timer and send them on their way.”
Beyond professional athletic programs, the medical device is growing in use among the general population and is covered by most worker’s compensation insurance carriers.
sam® Sport offers a non-invasive and non-addictive solution to eliminate America’s addiction to opioids and prescription drug abuse. George Lewis, Ph.D., Chief Executive Officer for ZetrOZ Systems, said: “The device is pre-approved by insurance for professional and collegiate athletes, and we have partnered with the largest insurance carriers to treat the workforce of America and get them off pain medication,” he explained. “The device allows the patient to obtain treatment while at work or on-the-go.”
sam® Sport is commonly prescribed for the non-invasive treatment of:
- Chronic tendinitis: elbow, bicep, tricep, shoulder;
- Shoulder/rotator cuff injuries and post-op recovery;
- Chronic back pain: lower back, sciatica and trapezius;
- Knee: meniscus tear and osteoarthritis (OA);
- Hamstring and groin strain and tears;
- Ankle injuries: sprain or frayed Achilles;
ZetrOZ Systems, LLC: ZetrOZ Systems, is a cGMP, ISO 13485 medical device manufacturer and sustained acoustic medicine pipeline development company. The company is the global leader in non-invasive medical devices to accelerate tissue healing and relieve pain for chronic musculoskeletal conditions.
For information, contact: Jim Molinaro Jr., chief commercial officer, ZetrOZ Systems LLC. [email protected] 888-507-8554


RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Cybersecurity Stocks Tumble After Anthropic's Claude Mythos AI Leak Sparks Market Fears
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand
Apple Turns 50: From Garage Startup to AI Crossroads
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
BlackRock CEO Larry Fink Earns $37.7 Million in 2025 Amid Record Growth
Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations
Bank of America's $72.5M Epstein Settlement: What You Need to Know
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Federal Judge Blocks Pentagon's Blacklisting of AI Company Anthropic 



